Year: 2010-11

Company: Allergan

Liaison(s): Fauad Hasan, Dennis Huang

Allergan is a multi-specialty company developing and commercializing biologics, pharmaceuticals and medical devices. Their leading products include BOTOX® (onabotulinumtoxinA), RESTASIS® (cyclosporine ophthalmic emulsion), LUMIGAN® (bimatoprost ophthalmic solution), BOTOX® Cosmetic (onabotulinumtoxinA), the JUVÉDERM® family of dermal fillers, and the LAP-BAND® Adjustable Gastric Banding System. This is the second TMP that Allergan has sponsored with KGI. Currently Allergan’s Biologics product pipeline is bottlenecked at the development phase of the product lifecycle. The TMP project‘s objective is to develop an outsourcing program that addresses the capacity problem. It serves as a complement to last year’s TMP which was focused on identifying internal remedies using a capacity modeling tool. The key deliverables for this year’s project are: 1. A vetted list of contract manufacturing organizations (CMOs) that can be used to match vendors with the project requirements 2. A business process to guide the selection, evaluation and management of CMOs 3. A strategy for optimizing internal vs. external developmental activities